Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffry P Simko

Showing results (61-70 of 99) with videos related to

Pageof 10
Sort By:
Contemporary Clinical Trials|January 9, 2023
Protocol for a 4-arm randomized controlled trial testing remotely delivered exercise-only, diet-only, and exercise + diet interventions among men with prostate cancer treated with radical prostatectomy (Prostate 8-II)Erin L Van Blarigan, June M Chan, Ada Sanchez, et al.
Cancer Medicine|November 13, 2019
Development and pilot evaluation of a personalized decision support intervention for low risk prostate cancer patientsJeffrey Belkora, June M Chan, Matthew R Cooperberg, et al.
JCI Insight|September 7, 2018
Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancerYang Su, Yue Liu, Christopher R Behrens, et al.
Urology|January 3, 2016
Patient-specific Meta-analysis of 2 Clinical Validation Studies to Predict Pathologic Outcomes in Prostate Cancer Using the 17-Gene Genomic Prostate ScoreTimothy C Brand, Nan Zhang, Michael R Crager, et al.
Cancer Immunology Research|October 1, 2016
Systemic GM-CSF Recruits Effector T Cells into the Tumor Microenvironment in Localized Prostate CancerXiao X Wei, Stephen Chan, Serena Kwek, et al.
The Journal of Molecular Diagnostics : JMD|March 6, 2016
Application of a Clinical Whole-Transcriptome Assay for Staging and Prognosis of Prostate Cancer Diagnosed in Needle Core Biopsy SpecimensBeatrice S Knudsen, Hyung L Kim, Nicholas Erho, et al.
Histopathology|October 16, 2025
In reply to: 'Prostate cancer with favorable histology is not synonymous with prostate cancer indolence'Jesse K McKenney, James D Brooks, Jane K Nguyen, et al.
Human Pathology|April 26, 2017
Pericytic tumors of the kidney-a clinicopathologic analysis of 17 casesDeepika Sirohi, Steven C Smith, Jonathan I Epstein, et al.
Oncogene|March 10, 2004
Integration of high-resolution array comparative genomic hybridization analysis of chromosome 16q with expression array data refines common regions of loss at 16q23-qter and identifies underlying candidate tumor suppressor genes in prostate cancerJ E Vivienne Watson, Norman A Doggett, Donna G Albertson, et al.
European Urology Oncology|July 20, 2023
Transcriptomic Heterogeneity of Expansile Cribriform and Other Gleason Pattern 4 Prostate Cancer SubtypesMeera R Chappidi, Martin Sjöström, Nancy Y Greenland, et al.
Pageof 10

Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
Contemporary Clinical Trials|January 9, 2023
Protocol for a 4-arm randomized controlled trial testing remotely delivered exercise-only, diet-only, and exercise + diet interventions among men with prostate cancer treated with radical prostatectomy (Prostate 8-II)Erin L Van Blarigan, June M Chan, Ada Sanchez, et al.
Cancer Medicine|November 13, 2019
Development and pilot evaluation of a personalized decision support intervention for low risk prostate cancer patientsJeffrey Belkora, June M Chan, Matthew R Cooperberg, et al.
JCI Insight|September 7, 2018
Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancerYang Su, Yue Liu, Christopher R Behrens, et al.
Urology|January 3, 2016
Patient-specific Meta-analysis of 2 Clinical Validation Studies to Predict Pathologic Outcomes in Prostate Cancer Using the 17-Gene Genomic Prostate ScoreTimothy C Brand, Nan Zhang, Michael R Crager, et al.
Cancer Immunology Research|October 1, 2016
Systemic GM-CSF Recruits Effector T Cells into the Tumor Microenvironment in Localized Prostate CancerXiao X Wei, Stephen Chan, Serena Kwek, et al.
The Journal of Molecular Diagnostics : JMD|March 6, 2016
Application of a Clinical Whole-Transcriptome Assay for Staging and Prognosis of Prostate Cancer Diagnosed in Needle Core Biopsy SpecimensBeatrice S Knudsen, Hyung L Kim, Nicholas Erho, et al.
Histopathology|October 16, 2025
In reply to: 'Prostate cancer with favorable histology is not synonymous with prostate cancer indolence'Jesse K McKenney, James D Brooks, Jane K Nguyen, et al.
Human Pathology|April 26, 2017
Pericytic tumors of the kidney-a clinicopathologic analysis of 17 casesDeepika Sirohi, Steven C Smith, Jonathan I Epstein, et al.
Oncogene|March 10, 2004
Integration of high-resolution array comparative genomic hybridization analysis of chromosome 16q with expression array data refines common regions of loss at 16q23-qter and identifies underlying candidate tumor suppressor genes in prostate cancerJ E Vivienne Watson, Norman A Doggett, Donna G Albertson, et al.
European Urology Oncology|July 20, 2023
Transcriptomic Heterogeneity of Expansile Cribriform and Other Gleason Pattern 4 Prostate Cancer SubtypesMeera R Chappidi, Martin Sjöström, Nancy Y Greenland, et al.
Pageof 10